NL Interview
Pharma woes: Dinesh Thakur and Prashant Reddy on India’s regulatory shortcomings
In their 2022 book The Truth Pill, lawyer Prashant Reddy T and public health activist Dinesh S Thakur explored various aspects of modern pharmacology and pharmaceutical practices in India.
Now, in this conversation with Newslaundry’s Abhinandan Sekhri on February 9, they talked about the shortcomings of pharmaceutical regulations in India. Prashant quoted a former drug controller, who said, “If I had to apply American standards of quality to the Indian industry, I’ll have to shut down more than half the plants.”
This lack of regulatory accountability and non-compliance with scientific methodology can have serious consequences for consumers. Dinesh and Prashant explained other pressing concerns facing healthcare in India – rising drug failures, a surge in fixed-dose combinations, and the lack of regulatory structures for ayurvedic medicines.
Watch.
Venue partner: The Quorum, Gurgaon
Also Read
-
‘They call us Bangladeshi’: Assam’s citizenship crisis and neglected villages
-
Why one of India’s biggest electoral bond donors is a touchy topic in Bhiwandi
-
‘Govt can’t do anything about court case’: Jindal on graft charges, his embrace of BJP and Hindutva
-
Reporter’s diary: Assam is better off than 2014, but can’t say the same for its citizens
-
‘INDIA coalition set to come to power’: RJD’s Tejashwi Yadav on polls, campaign and ECI